NCT00592839 - Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Nocturnal Vasomotor Symptoms

Interventions

DRUG

SCE-B

0.3 mg or 0.625 mg SCE-B tablets daily plus matching placebo

DRUG

Placebo

Matching placebo for 0.3 mg and 0.625 mg tablets

Trial Locations (17)

15206

Duramed Investigational Site, Pittsburgh

27103

Duramed Investigational Site, Winston-Salem

29201

Duramed Investigational Site, Columbia

33409

Duramed Investigational Site, West Palm Beach

33759

Duramed Investigational Site, Clearwater

40291

Duramed Investigational Site, Louisville

40509

Duramed Investigational Site, Lexington

44122

Duramed Investigational Site, Cleveland

44124

Duramed Investigational Site, Mayfield Heights

68510

Duramed Investigational Site, Lincoln

78229

Duramed Investigational Site, San Antonio

87102

Duramed Investigational Site, Albuquerque

92108

Duramed Investigational Site, San Diego

92801

Duramed Investigational Site, Anaheim

95821

Duramed Investigational Site, Sacramento

97504

Duramed Investigational Site, Medford

08057

Duramed Investigational Site, Moorestown